Astellas Pharma

(OTC) ALPMF

Current Price$13.67

Market Cap$25.44B

Since IPO (2003)-48%

5 Year-4%

1 Year+48%

1 Month-11%

Astellas Pharma Financials at a Glance

Market Cap

$25.44B

Revenue (TTM)

¥2.15T

Net Income (TTM)

¥293.07B

EPS (TTM)

$1.08

P/E Ratio

13.11

Dividend

$0.51

Beta (Volatility)

0.06 (Low)

Dividend

$0.51

Beta (Volatility)

0.06 (Low)

Price

$13.67

Volume

758

Open

$12.85

Price

$13.67

Volume

758

Open

$12.85

Previous Close

$13.67

Daily Range

$12.85 - $14.50

52-Week Range

$9.34 - $17.85

Estimated Earnings Date

Aug 5, 2026

Dividend

$0.51

Beta (Volatility)

0.06 (Low)

Price

$13.67

Volume

758

Open

$12.85

Previous Close

$13.67

Daily Range

$12.85 - $14.50

52-Week Range

$9.34 - $17.85

Estimated Earnings Date

Aug 5, 2026

ALPMF News

A $20 Billion Sweet Spot in Biotech

David HaenDec 28, 2019

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Astellas Pharma

Industry

Pharmaceuticals

Sector

Health Care

Employees

14,099

CEO

Naoki Okamura

Website

www.astellas.com

Headquarters

Tokyo, 103-8411, JP

ALPMF Financials

Key Financial Metrics (TTM)

Gross Margin

76.08%

Operating Margin

18.92%

Net Income Margin

13.63%

Return on Equity

17.44%

Return on Capital

17.51%

Return on Assets

8.17%

Earnings Yield

7.63%

Dividend Yield

3.58%

Payout Ratio

46.68%

Stock Overview

Market Cap

$25.44B

Shares Outstanding

1.79B

Volume

758

Avg. Volume

7.21K

Financials (TTM)

Gross Profit

¥1.64T

Operating Income

¥406.98B

EBITDA

¥622.98B

Operating Cash Flow

¥569.87B

Capital Expenditure

-¥58.03B

Free Cash Flow

¥511.84B

Cash & ST Invst.

¥283.38B

Total Debt

¥569.51B

Astellas Pharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2026YOY CHG

Revenue

¥541.31B

+17.9%

Gross Profit

¥411.07B

+7.5%

Gross Margin

75.94%

N/A

Market Cap

$25.44B

N/A

Market Cap/Employee

$1.72M

N/A

Employees

14,754

N/A

Net Income

¥43.89B

-41.4%

EBITDA

¥129.02B

+26.8%

Quarterly Fundamentals

Name

Q4 2026YOY CHG

Total Cash

¥283.38B

+29.8%

Total Debt

¥569.51B

-31.5%

Accounts Receivable

¥766.56B

+21.2%

Inventory

¥333.10B

+12.1%

Long Term Debt

¥322.01B

-43.0%

Short Term Debt

¥247.50B

-7.1%

Return on Assets

8.17%

N/A

Return on Invested Capital

17.24%

N/A

Free Cash Flow

¥189.72B

+107.6%

Operating Cash Flow

¥206.42B

+104.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ORINYOrion Oyj

ORINYOrion Oyj$38.86+0.00%

WXXWYWuXi Biologics (Cayman) Inc.

WXXWYWuXi Biologics (Cayman) Inc.$8.95+4.07%

WXIBFWuXi Biologics (Cayman) Inc.

WXIBFWuXi Biologics (Cayman) Inc.$4.00+0.00%

GNMSFGenmab A/S

GNMSFGenmab A/S$262.00+0.00%

SONVYSonova Holding AG

SONVYSonova Holding AG$47.36-1.19%

GIKLYGrifols, S.A.

GIKLYGrifols, S.A.$5.10+0.00%

FMCQFFresenius Medical Care AG

FMCQFFresenius Medical Care AG$45.17+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CMCSAComcast

CMCSAComcast$24.22+0.05%

TAT&T

TAT&T$21.82-0.04%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.64+0.17%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.19+0.07%

SOFISoFi Technologies

SOFISoFi Technologies$18.19+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$38.16-0.08%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.49-0.03%

Questions About ALPMF

What is the current price of Astellas Pharma?

Astellas Pharma is trading at $13.67 per share.

What is the 52-week range for Astellas Pharma?

Over the past 52 weeks, Astellas Pharma has traded between $9.34 and $17.85.

How much debt does Astellas Pharma have?

As of the most recent reporting period, Astellas Pharma reported total debt of ¥4.23B.

How much cash does Astellas Pharma have on hand?

Astellas Pharma reported ¥1.77B in cash and cash equivalents in its most recent financial results.

What is Astellas Pharma’s dividend yield?

Astellas Pharma currently has a dividend yield of 3.58%.

Astellas Pharma

Astellas Pharma Financials at a Glance

ALPMF News

A $20 Billion Sweet Spot in Biotech

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Astellas Pharma

ALPMF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Astellas Pharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ALPMF

What is the current price of Astellas Pharma?

What is the 52-week range for Astellas Pharma?

How much debt does Astellas Pharma have?

How much cash does Astellas Pharma have on hand?

What is Astellas Pharma’s dividend yield?

Premium Investing Services